HomepageA MEETING WITH REPRESENTATIVES OF ROCHE KAZAKHSTAN WAS HELD AT MEDICAL CENTER HOSPITAL OF THE PRE...

A MEETING WITH REPRESENTATIVES OF ROCHE KAZAKHSTAN WAS HELD AT MEDICAL CENTER HOSPITAL OF THE PRESIDENT’S AFFAIRS ADMINISTRATION OF THE REPUBLIC OF KAZAKHSTAN

A MEETING WITH REPRESENTATIVES OF ROCHE KAZAKHSTAN WAS HELD AT MEDICAL CENTER HOSPITAL OF THE PRESIDENT’S AFFAIRS ADMINISTRATION OF THE REPUBLIC OF KAZAKHSTAN A MEETING WITH REPRESENTATIVES OF ROCHE KAZAKHSTAN WAS HELD AT MEDICAL CENTER HOSPITAL OF THE PRESIDENT’S AFFAIRS ADMINISTRATION OF THE REPUBLIC OF KAZAKHSTAN A MEETING WITH REPRESENTATIVES OF ROCHE KAZAKHSTAN WAS HELD AT MEDICAL CENTER HOSPITAL OF THE PRESIDENT’S AFFAIRS ADMINISTRATION OF THE REPUBLIC OF KAZAKHSTAN

Lyudmila Rakovich, Medical Director of Scientific Support Department of Roche Kazakhstan, Inna Gannibal Professional, Development Partner, Margulan Ospanov, Head of Strategic Interaction with Market Development and Government Institutions, Timur Amanbekov, Health System Interaction Partner, Almat Zhumabaev, Project Manager “Kazakh Invest” took part in the meeting. In the course of the event, the company representatives were acquainted with the capabilities of the devices in the diagnostic unit of the Hospital, the work of cyclotron-production complex, the departments of neurology, rehabilitation and therapeutic care.

The Swiss Holding Roche, part of the Hoffmann group of companies, is one of the world leaders in the field of pharmaceuticals and diagnostics. In 1993, the company opened a representative office in Kazakhstan. Since 2013, Roche Kazakhstan LLP represents the interests of the holding.

As a result of the meeting, further directions and steps of partnership were defined for the exchange of experience between doctors, organization and conduct of educational activities for doctors and nurses, as well as the use of telemedicine.

Alexey Tsoy, Head of the Medical Center of the President’s Affairs Administration of the Republic of Kazakhstan wished success to representatives of Roche Kazakhstan and expressed confidence that they will make a significant contribution to the development and prosperity of Kazakhstani medicine. He also noted that in the future a close partnership with the company would be developed in the scientific direction.